Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Molecular Cell
|
September 25, 2021
Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Junwei Hou, Jung-Mao Hsu, Mien-Chie Hung
Nature Reviews. Clinical Oncology
|
February 8, 2022
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wen-Hao Yang, et al.
Biochemical and Biophysical Research Communications
|
May 24, 2021
The N-linked glycosylations of TIGIT Asn<sup>32</sup> and Asn<sup>101</sup> facilitate PVR/TIGIT interaction
Yu-Xi Lin, Mien-Chie Hung, Jye-Lin Hsu, et al.
Cancer Research
|
November 17, 2018
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Jung-Mao Hsu, Chia-Wei Li, Yun-Ju Lai, et al.
Seminars in Immunology
|
August 30, 2023
Gasdermins and cancers
Junwei Hou, Tiansheng Li, Jung-Mao Hsu, et al.
Cell Reports. Medicine
|
June 21, 2024
Advances and prospects of biomarkers for immune checkpoint inhibitors
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
The Journal of Biological Chemistry
|
May 18, 2004
Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region
Jung-Mao Hsu, Yuan-Chii G Lee, Chang-Tze R Yu, et al.
Science (New York, N.Y.)
|
October 9, 2025
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
Jung-Mao Hsu, Chunxiao Liu, Weiya Xia, et al.
Molecular Cancer Therapeutics
|
July 25, 2012
Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer
Chun-Te Chen, Yi Du, Hirohito Yamaguchi, et al.
American Journal of Cancer Research
|
May 21, 2019
Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer
Ye Han, Chia-Wei Li, Jung-Mao Hsu, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Molecular Cell
|
September 25, 2021
Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Junwei Hou, Jung-Mao Hsu, Mien-Chie Hung
Nature Reviews. Clinical Oncology
|
February 8, 2022
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wen-Hao Yang, et al.
Biochemical and Biophysical Research Communications
|
May 24, 2021
The N-linked glycosylations of TIGIT Asn<sup>32</sup> and Asn<sup>101</sup> facilitate PVR/TIGIT interaction
Yu-Xi Lin, Mien-Chie Hung, Jye-Lin Hsu, et al.
Cancer Research
|
November 17, 2018
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Jung-Mao Hsu, Chia-Wei Li, Yun-Ju Lai, et al.
Seminars in Immunology
|
August 30, 2023
Gasdermins and cancers
Junwei Hou, Tiansheng Li, Jung-Mao Hsu, et al.
Cell Reports. Medicine
|
June 21, 2024
Advances and prospects of biomarkers for immune checkpoint inhibitors
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
The Journal of Biological Chemistry
|
May 18, 2004
Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region
Jung-Mao Hsu, Yuan-Chii G Lee, Chang-Tze R Yu, et al.
Science (New York, N.Y.)
|
October 9, 2025
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
Jung-Mao Hsu, Chunxiao Liu, Weiya Xia, et al.
Molecular Cancer Therapeutics
|
July 25, 2012
Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer
Chun-Te Chen, Yi Du, Hirohito Yamaguchi, et al.
American Journal of Cancer Research
|
May 21, 2019
Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer
Ye Han, Chia-Wei Li, Jung-Mao Hsu, et al.
Page
of 6